Quest Diagnostics Stock

Quest Diagnostics Market capitalization 2025

Quest Diagnostics Market capitalization

20.8 B USD

Ticker

DGX

ISIN

US74834L1008

WKN

904533

In 2025, Quest Diagnostics's market cap stood at 20.8 B USD, a 18.32% increase from the 17.58 B USD market cap in the previous year.

The Quest Diagnostics Market capitalization history

YEARMarket Capitalization (B USD)
202416.16
202315.41
202216.25
202117.19
202015.31
201913.27
201814.25
201714.07
201611.14
201510.24
20148.6
20139.04
20129.45
20118.82
20109.34
20099.95
20089.64
200710.31
200611.01
200510.39

Quest Diagnostics Aktienanalyse

What does Quest Diagnostics do?

Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Quest Diagnostics's Market Capitalization

Quest Diagnostics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Quest Diagnostics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Quest Diagnostics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Quest Diagnostics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Quest Diagnostics stock

What is the current Quest Diagnostics market capitalization?

The current market capitalization of Quest Diagnostics is 20.8 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Quest Diagnostics.

How has the market capitalization of Quest Diagnostics developed in recent years?

The market capitalization of Quest Diagnostics has increased/decreased by 18.32% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Quest Diagnostics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Quest Diagnostics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Quest Diagnostics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Quest Diagnostics pay?

Over the past 12 months, Quest Diagnostics paid a dividend of 3 USD . This corresponds to a dividend yield of about 1.63 %. For the coming 12 months, Quest Diagnostics is expected to pay a dividend of 2.56 USD.

What is the dividend yield of Quest Diagnostics?

The current dividend yield of Quest Diagnostics is 1.63 %.

When does Quest Diagnostics pay dividends?

Quest Diagnostics pays a quarterly dividend. This is distributed in the months of February, May, August, November.

How secure is the dividend of Quest Diagnostics?

Quest Diagnostics paid dividends every year for the past 25 years.

What is the dividend of Quest Diagnostics?

For the upcoming 12 months, dividends amounting to 2.56 USD are expected. This corresponds to a dividend yield of 1.39 %.

In which sector is Quest Diagnostics located?

Quest Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quest Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quest Diagnostics from 10/20/2025 amounting to 0.8 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2025.

When did Quest Diagnostics pay the last dividend?

The last dividend was paid out on 10/20/2025.

What was the dividend of Quest Diagnostics in the year 2024?

In the year 2024, Quest Diagnostics distributed 2.84 USD as dividends.

In which currency does Quest Diagnostics pay out the dividend?

The dividends of Quest Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Quest Diagnostics

Our stock analysis for Quest Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.